Baxter (NYSE: BAX) reported Q2 EPS of $0.64, $0.07 worse than the analyst estimate of $0.71. Revenue for the quarter came in at $2.7 billion versus the consensus estimate of $2.87 billion.

GUIDANCE:

Baxter sees FY2020 EPS of $3.00-$3.10, versus the consensus of $3.30.

For earnings history and earnings-related data on Baxter (BAX) click here.